Amicus Therapeutics Net Income 2007-2020 | FOLD

Amicus Therapeutics net income from 2007 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Amicus Therapeutics Annual Net Income
(Millions of US $)
2019 $-356
2018 $-349
2017 $-284
2016 $-200
2015 $-132
2014 $-69
2013 $-60
2012 $-49
2011 $-44
2010 $-55
2009 $-7
2008 $-39
2007 $-42
2006 $-42
2005 $-20
Amicus Therapeutics Quarterly Net Income
(Millions of US $)
2020-06-30 $-52
2020-03-31 $-89
2019-12-31 $-90
2019-09-30 $-62
2019-06-30 $-85
2019-03-31 $-120
2018-12-31 $-78
2018-09-30 $-159
2018-06-30 $-62
2018-03-31 $-50
2017-12-31 $-69
2017-09-30 $-112
2017-06-30 $-48
2017-03-31 $-55
2016-12-31 $-59
2016-09-30 $-47
2016-06-30 $-51
2016-03-31 $-44
2015-12-31 $-43
2015-09-30 $-38
2015-06-30 $-27
2015-03-31 $-24
2014-12-31 $-21
2014-09-30 $-17
2014-06-30 $-15
2014-03-31 $-16
2013-12-31 $-12
2013-09-30 $-15
2013-06-30 $-15
2013-03-31 $-17
2012-12-31 $-10
2012-09-30 $-16
2012-06-30 $-9
2012-03-31 $-13
2011-12-31 $-9
2011-09-30 $-10
2011-06-30 $-13
2011-03-31 $-13
2010-12-31 $-15
2010-09-30 $-15
2010-06-30 $-11
2010-03-31 $-13
2009-12-31 $33
2009-09-30 $-13
2009-06-30 $-14
2009-03-31 $-12
2008-12-31 $-14
2008-09-30 $-8
2008-06-30 $-9
2008-03-31 $-8
2007-12-31 $-12
2007-09-30 $-10
2007-06-30 $-10
2007-03-31 $-10
2006-09-30 $-12
2006-06-30 $-28
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.749B $0.182B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $131.055B 10.09
Amgen (AMGN) United States $127.576B 13.26
CSL (CSLLY) Australia $94.443B 0.00
Gilead Sciences (GILD) United States $73.380B 9.76
Regeneron Pharmaceuticals (REGN) United States $59.132B 22.61
Vertex Pharmaceuticals (VRTX) United States $53.919B 25.03
Illumina (ILMN) United States $45.975B 63.23
Biogen (BIIB) United States $37.775B 6.71
Seattle Genetics (SGEN) United States $33.467B 91.59
Moderna (MRNA) United States $28.126B 0.00
BeiGene (BGNE) Cayman Islands $27.144B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.908B 10.31
Genmab (GMAB) Denmark $22.492B 14.19
Genmab (GNMSF) Denmark $21.358B 4.92
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.298B 0.00
BioNTech SE (BNTX) Germany $19.189B 0.00
Incyte (INCY) United States $19.031B 0.00
Exact Sciences (EXAS) United States $18.127B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 65.10
Horizon Therapeutics Public (HZNP) Ireland $16.046B 37.55
Alnylam Pharmaceuticals (ALNY) United States $14.301B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.496B 97.92
ARGENX SE-ADR (ARGX) Netherlands $11.958B 0.00
MyoKardia (MYOK) United States $11.837B 0.00
Sarepta Therapeutics (SRPT) United States $11.108B 0.00
Guardant Health (GH) United States $10.905B 0.00
QIAGEN (QGEN) Netherlands $10.841B 24.41
Bio-Techne Corp (TECH) United States $9.859B 67.64
Mirati Therapeutics (MRTX) United States $9.798B 0.00
Repligen (RGEN) United States $9.042B 143.52
Ascendis Pharma (ASND) Denmark $8.667B 0.00
Galapagos (GLPG) Belgium $7.632B 27.61
ACADIA Pharmaceuticals (ACAD) United States $7.466B 0.00
Adaptive Biotechnologies (ADPT) United States $7.040B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.807B 0.00
Exelixis (EXEL) United States $6.464B 23.51
Acceleron Pharma (XLRN) United States $6.402B 0.00
Blueprint Medicines (BPMC) United States $5.905B 19.71
Ultragenyx Pharmaceutical (RARE) United States $5.799B 0.00
Novavax (NVAX) United States $5.370B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.031B 13.75
Arena Pharmaceuticals (ARNA) United States $4.846B 0.00
Denali Therapeutics (DNLI) United States $4.829B 0.00
Emergent Biosolutions (EBS) United States $4.804B 19.03
China Biologic Products (CBPO) China $4.575B 27.15
NeoGenomics (NEO) United States $4.566B 1378.33
Vir Biotechnology (VIR) United States $4.298B 0.00
Fate Therapeutics (FATE) United States $3.963B 0.00
Halozyme Therapeutics (HALO) United States $3.959B 0.00
Reata Pharmaceuticals (RETA) United States $3.954B 0.00
Twist Bioscience (TWST) United States $3.544B 0.00
Bluebird Bio (BLUE) United States $3.503B 0.00
Legend Biotech (LEGN) United States $3.360B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.325B 0.00
MorphoSys AG (MOR) Germany $3.318B 43.48
Global Blood Therapeutics (GBT) United States $3.274B 0.00
Insmed (INSM) United States $3.214B 0.00
Eidos Therapeutics (EIDX) United States $2.782B 0.00
Alkermes (ALKS) Ireland $2.589B 25.44
PHARMA MAR SA (PHMMF) Spain $2.348B 0.00
I-Mab (IMAB) China $2.329B 0.00
Seres Therapeutics (MCRB) United States $2.277B 0.00
Editas Medicine (EDIT) United States $2.042B 0.00
Amarin (AMRN) Ireland $1.924B 0.00
Sorrento Therapeutics (SRNE) United States $1.905B 0.00
Beam Therapeutics (BEAM) United States $1.878B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.837B 0.00
Zymeworks (ZYME) Canada $1.824B 0.00
UniQure (QURE) Netherlands $1.791B 0.00
Viela Bio (VIE) United States $1.791B 0.00
Inovio Pharmaceuticals (INO) United States $1.757B 0.00
Revance Therapeutics (RVNC) United States $1.715B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.616B 18.10
Intra-Cellular Therapies (ITCI) United States $1.614B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.593B 0.00
Arcus Biosciences (RCUS) United States $1.520B 0.00
Sangamo Therapeutics (SGMO) United States $1.496B 0.00
Intellia Therapeutics (NTLA) United States $1.466B 0.00
Zealand Pharma (ZEAL) Denmark $1.346B 0.00
Alcobra (ARCT) United States $1.346B 0.00
Ligand Pharmaceuticals (LGND) United States $1.336B 45.15
Epizyme (EPZM) United States $1.281B 0.00
Mesoblast (MESO) Australia $1.279B 0.00
Coherus BioSciences (CHRS) United States $1.226B 7.15
Mersana Therapeutics (MRSN) United States $1.223B 0.00
Scholar Rock Holding (SRRK) United States $1.209B 0.00
Zealand Pharma (ZLDPF) Denmark $1.196B 0.00
NGM Biopharmaceuticals (NGM) United States $1.189B 0.00
Heska (HSKA) United States $1.095B 0.00
REGENXBIO (RGNX) United States $1.095B 0.00
Cytokineticsorporated (CYTK) United States $1.092B 0.00
Retrophin (RTRX) United States $1.058B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.997B 0.00
Myriad Genetics (MYGN) United States $0.983B 0.00
Northwest Biotherapeutics (NWBO) United States $0.961B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.954B 0.00
Athenex (ATNX) United States $0.938B 0.00
Castle Biosciences (CSTL) United States $0.927B 0.00
Compugen (CGEN) Israel $0.927B 0.00
Adverum Biotechnologies (ADVM) United States $0.905B 0.00
Genetron Holdings (GTH) China $0.892B 0.00
NantKwest (NK) United States $0.868B 0.00
Arvinas (ARVN) United States $0.860B 0.00
Vericel (VCEL) United States $0.852B 0.00
Codexis (CDXS) United States $0.811B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.804B 0.00
AnaptysBio (ANAB) United States $0.800B 0.00
Morphic Holding (MORF) United States $0.796B 0.00
Intrexon (PGEN) United States $0.784B 0.00
Pliant Therapeutics (PLRX) United States $0.763B 0.00
Alector (ALEC) United States $0.755B 0.00
Frequency Therapeutics (FREQ) United States $0.722B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.695B 0.00
Cellectis S.A (CLLS) France $0.695B 0.00
Agenus (AGEN) United States $0.682B 0.00
Protagonist Therapeutics (PTGX) United States $0.681B 0.00
Pharming Group (PHGUF) Netherlands $0.670B 15.29
Sinovac Biotech (SVA) China $0.640B 43.13
MiMedx (MDXG) United States $0.638B 0.00
Cara Therapeutics (CARA) United States $0.618B 0.00
Celldex Therapeutics (CLDX) United States $0.602B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.601B 30.53
Adaptimmune Therapeutics (ADAP) United Kingdom $0.589B 0.00
Kadmon Holdings (KDMN) United States $0.584B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
VBI Vaccines (VBIV) United States $0.576B 0.00
Geron (GERN) United States $0.565B 0.00
IVERIC Bio (ISEE) United States $0.546B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.514B 0.00
MeiraGTx Holdings (MGTX) United States $0.509B 0.00
Albireo Pharma (ALBO) United States $0.490B 0.00
Cel-Sci (CVM) United States $0.485B 0.00
UROGEN PHARMA (URGN) United States $0.480B 0.00
Anika Therapeutics (ANIK) United States $0.477B 20.83
Sutro Biopharma (STRO) United States $0.474B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.473B 0.00
MannKind (MNKD) United States $0.470B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.469B 0.00
Clovis Oncology (CLVS) United States $0.454B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.453B 0.00
Prothena (PRTA) Ireland $0.449B 0.00
Amryt Pharma (AMYT) United Kingdom $0.446B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Dynavax Technologies (DVAX) United States $0.427B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.413B 0.00
Forte Biosciences (FBRX) United States $0.408B 0.00
Starpharma Holdings (SPHRY) Australia $0.406B 0.00
Kala Pharmaceuticals (KALA) United States $0.391B 0.00
Cardiff Oncology (CRDF) United States $0.386B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
Puma Biotechnology (PBYI) United States $0.361B 0.00
Cue Biopharma (CUE) United States $0.357B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.356B 0.00
Cellular Biomedicine (CBMG) United States $0.355B 0.00
Athersys (ATHX) United States $0.353B 0.00
Precision BioSciences (DTIL) United States $0.351B 0.00
Selecta Biosciences (SELB) United States $0.347B 0.00
Spero Therapeutics (SPRO) United States $0.347B 0.00
AC Immune SA (ACIU) Switzerland $0.341B 0.00
Trevena (TRVN) United States $0.337B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.337B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.333B 0.00
ANI Pharmaceuticals (ANIP) United States $0.324B 7.65
IBio (IBIO) United States $0.319B 0.00
Kamada (KMDA) Israel $0.316B 15.11
Innate Pharma S.A (IPHA) France $0.316B 0.00
BioDelivery Sciences (BDSI) United States $0.315B 22.29
Syros Pharmaceuticals (SYRS) United States $0.315B 0.00
CytomX Therapeutics (CTMX) United States $0.313B 0.00
NextCure (NXTC) United States $0.286B 0.00
ChromaDex (CDXC) United States $0.285B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.277B 0.00
XOMA (XOMA) United States $0.275B 0.00
WAVE Life Sciences (WVE) Singapore $0.266B 0.00
Affimed (AFMD) Germany $0.250B 0.00
PDL BioPharma (PDLI) United States $0.248B 0.00
Pluristem Therapeutics (PSTI) Israel $0.238B 0.00
Arbutus Biopharma (ABUS) United States $0.238B 0.00
TELA Bio (TELA) United States $0.227B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.221B 0.00
HOOKIPA Pharma (HOOK) United States $0.216B 0.00
Verastem (VSTM) United States $0.210B 0.00
Fortress Biotech (FBIO) United States $0.209B 0.00
Dyadic (DYAI) United States $0.206B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.185B 0.00
Five Prime Therapeutics (FPRX) United States $0.179B 0.00
ADMA Biologics Inc (ADMA) United States $0.175B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.174B 0.00
Liquidia Technologies (LQDA) United States $0.170B 0.00
Cerecor (CERC) United States $0.163B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
VolitionRX (VNRX) United States $0.156B 0.00
DBV Technologies S.A (DBVT) France $0.154B 0.00
Biofrontera AG (BFRA) Germany $0.150B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Nicox SA (NICXF) France $0.149B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
Kindred Biosciences (KIN) United States $0.146B 0.00
Aptinyx (APTX) United States $0.144B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.144B 0.00
Bellus Health (BLU) Canada $0.143B 0.00
Checkpoint Therapeutics (CKPT) United States $0.142B 0.00
GENFIT S.A (GNFT) France $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.136B 0.00
Exicure (XCUR) United States $0.131B 0.00
Catalyst Biosciences (CBIO) United States $0.129B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.128B 0.00
AquaBounty Technologies (AQB) United States $0.127B 0.00
SESEN BIO, INC (SESN) United States $0.127B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.124B 0.00
VTv Therapeutics (VTVT) United States $0.124B 0.00
Aytu Bioscience (AYTU) United States $0.123B 0.00
Unum Therapeutics (COGT) United States $0.121B 0.00
Lumos Pharma (LUMO) United States $0.121B 0.00
Prometic Life Sciences (LMNL) Canada $0.118B 0.00
Cidara Therapeutics (CDTX) United States $0.114B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Protalix BioTherapeutics (PLX) Israel $0.109B 0.00
Gritstone Oncology (GRTS) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.104B 0.00
Idera Pharmaceuticals (IDRA) United States $0.103B 0.00
Orgenesis (ORGS) United States $0.103B 5.24
Strongbridge Biopharma (SBBP) United States $0.103B 0.00
Oncobiologics (OTLK) United States $0.102B 0.00
Enzo Biochem (ENZ) United States $0.094B 0.00
Palatin Technologies (PTN) United States $0.094B 0.00
AIT Therapeutics (XAIR) United States $0.093B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Abeona Therapeutics (ABEO) United States $0.092B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.085B 0.00
Ecology Coatings (ABVC) United States $0.083B 0.00
Signal Genetics (MGEN) United States $0.079B 0.00
Cyclerion Therapeutics (CYCN) United States $0.078B 0.00
DiaMedica Therapeutics (DMAC) United States $0.077B 0.00
ARAVIVE, INC (ARAV) United States $0.077B 0.00
Evogene (EVGN) Israel $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.073B 69.99
Bionano Genomics (BNGO) United States $0.071B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Biorestorative Therapies (BRTXQ) United States $0.069B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
Appili Therapeutics (APLIF) Canada $0.063B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
AmpliPhi Biosciences (ARMP) United States $0.060B 0.00
Edesa Biotech (EDSA) Canada $0.059B 0.00
TRACON Pharmaceuticals (TCON) United States $0.059B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.058B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.052B 0.00
Soligenix (SNGX) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.050B 0.00
Acorda Therapeutics (ACOR) United States $0.044B 0.00
Cocrystal Pharma (COCP) United States $0.044B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Genetic Technologies (GENE) Australia $0.041B 0.00
Novogen (KZIA) Australia $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
IMMURON (IMRN) Australia $0.039B 0.00
AnPac Bio-Medical Science (ANPC) China $0.038B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.035B 0.00
Cleveland BioLabs (CBLI) United States $0.035B 0.00
Seelos Therapeutics (SEEL) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
OvaScience (MLND) United States $0.028B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.027B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Advaxis (ADXS) United States $0.025B 0.00
Aptevo Therapeutics (APVO) United States $0.021B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
Alimera Sciences (ALIM) United States $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.020B 0.00
Celsion (CLSN) United States $0.018B 0.00
Spherix (AIKI) United States $0.018B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00